Clinical Trial Update: A Study Assessing the Safety, Efficacy, and Impact of GlaxoSmithKline Biologicals' RTS, S/AS01E Malaria Vaccine in Young Children Across Sub-Saharan Africa

View source ↗

Summary

Completed clinical trial assessing safety, efficacy, and impact of GlaxoSmithKline's RTS,S/AS01E malaria vaccine (Mosquirix) in young children across Sub-Sahara…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Mosquirix (RTS,S/AS01E)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Malaria, Malaria Vaccines | Status: COMPLETED